Diabetes Technology Use in Special Populations: A Narrative Review of Psychosocial Factors

As diabetes technologies continue to advance, their use is expanding beyond type 1 diabetes to include populations with type 2 diabetes, older adults, pregnant individuals, those with psychiatric conditions, and hospitalized patients. This review examines the psychosocial outcomes of these technologies across these diverse groups, with a focus on treatment satisfaction, quality of life, and self-management behaviors. Despite demonstrated benefits in glycemic outcomes, the adoption and sustained use of these technologies face unique challenges in each population. By highlighting existing research and identifying gaps, this review seeks to emphasize the need for targeted studies and tailored support strategies to understand and optimize psychosocial outcomes and well-being.

• Publication year

  2024

• Venue

  Journal of Diabetes Science and Technology

• Publication date

  2024-11-20

• Fields of study

  Medicine, Psychology

• Identifiers
  DOI 10.1177/19322968241296853PMID 39564761PMCID PMC11577555
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• A Diabetes Pregnancy Technology Roadmap: The 2023 Norbert Freinkel Award Lecture.

  2024cited by this paper
• Empowering Hospitalized Patients With Diabetes: Implementation of a Hospital-wide CGM Policy With EHR-Integrated Validation for Dosing Insulin.

  2024cited by this paper
• 1456-P: Type 1 Diabetes Care and Device Use in Older Adults—Transatlantic Comparison Based on T1DX-QI and DPV Registries

  2024cited by this paper
• 976-P: Diabetes Technology Use in U.S. Hospitals

  2024cited by this paper
• Comparing advanced hybrid closed loop therapy and standard insulin therapy in pregnant women with type 1 diabetes (CRISTAL): a parallel-group, open-label, randomised controlled trial.

  2024cited by this paper
• The Potential Impact of Continuous Glucose Monitoring Use on Diabetes-Related Attitudes and Behaviors in Adults with Type 2 Diabetes: A Qualitative Investigation of the Patient Experience

  2024cited by this paper
• Real-World Evidence of Off-Label Use of Commercially Automated Insulin Delivery Systems Compared to Multiple Daily Insulin Injections in Pregnancies Complicated by Type 1 Diabetes

  2024cited by this paper
• 13. Older Adults: Standards of Care in Diabetes-2024.

  2023cited by this paper
• Associations Between Hypoglycemia Awareness, Hypoglycemia Beliefs, and Continuous Glucose Monitoring Glycemic Profiles and Anxiety and Depression Symptoms in Adults with Type 1 Diabetes Using Advanced Diabetes Technologies.

  2023cited by this paper
• 8. Obesity and Weight Management for the Prevention and Treatment of Type 2 Diabetes: Standards of Care in Diabetes-2024.

  2023cited by this paper
• At-Home Use of a Pregnancy-Specific Zone-MPC Closed-Loop System for Pregnancies Complicated by Type 1 Diabetes: A Single-Arm, Observational Multicenter Study

  2023cited by this paper
• Nursing Perspectives on the Use of Continuous Glucose Monitoring in the Intensive Care Unit

  2023cited by this paper
• Real-Time Continuous Glucose Monitoring in the Hospital: A Real-World Experience

  2023cited by this paper
• Time requirements for perioperative glucose management using fully closed‐loop versus standard insulin therapy: A proof‐of‐concept time–motion study

  2023cited by this paper
• Implementation of Continuous Glucose Monitoring in Critical Care: A Scoping Review

  2023cited by this paper
• Continuous Glucose Monitoring in Adults with Diabetes in Clinical Practice: Increased Access and Education Needed

  2023cited by this paper
• Real‐world use of Control‐IQ™ technology automated insulin delivery in pregnancy: A case series with qualitative interviews

  2023cited by this paper
• Safety and Efficacy of the Omnipod 5 Automated Insulin Delivery System in Adults With Type 2 Diabetes: From Injections to Hybrid Closed-Loop Therapy

  2023cited by this paper
• Expert Guidance on Off-Label Use of Hybrid Closed-Loop Therapy in Pregnancies Complicated by Diabetes

  2023cited by this paper
• Fully automated closed-loop insulin delivery in adults with type 2 diabetes: an open-label, single-center, randomized crossover trial

  2023cited by this paper
• 7. Diabetes Technology: Standards of Care in Diabetes-2024.

  2023cited by this paper
• A conceptual model of the continuous glucose monitoring integration process for older adults with diabetes developed using participatory systems science methods.

  2023cited by this paper
• 16. Diabetes Care in the Hospital: Standards of Care in Diabetes-2024.

  2023cited by this paper
• 15. Management of Diabetes in Pregnancy: Standards of Care in Diabetes-2024.

  2023cited by this paper
• Digital Technology for Diabetes.

  2023cited by this paper
• Continuous glucose monitoring in older adults with diabetes: Data from the diabetes prospective follow‐up (DPV) registry

  2023cited by this paper
• Automated Insulin Delivery in Women with Pregnancy Complicated by Type 1 Diabetes.

  2023cited by this paper
• Psychosocial and Glycemic Benefits for Insulin-Using Adults With Type 2 Diabetes After Six Months of Pump Therapy: A Quasi-Experimental Approach

  2023cited by this paper
• A Consensus Statement for Continuous Glucose Monitoring Metrics for Inpatient Clinical Trials

  2023cited by this paper
• Automated Insulin Delivery with Remote Real-Time Continuous Glucose Monitoring for Hospitalized Patients with Diabetes: A Multicenter, Single-Arm, Feasibility Trial

  2023cited by this paper
• The Growing Role of Technology in the Care of Older Adults With Diabetes.

  2023influential reference
• Management of type 1 diabetes in pregnancy: update on lifestyle, pharmacological treatment, and novel technologies for achieving glycaemic targets.

  2023cited by this paper
• Supporting the ‘lived expertise’ of older adults with type 1 diabetes: An applied focus group analysis to characterize barriers, facilitators, and strategies for self‐management in a growing and understudied population

  2023cited by this paper
• Patient-reported outcomes for people with diabetes: what and how to measure? A narrative review

  2023cited by this paper
• The Influence of Real-Time Continuous Glucose Monitoring on Psychosocial Outcomes in Insulin-Using Type 2 Diabetes

  2022cited by this paper
• Prevalence of mental, behavioral, and developmental disorders among children and adolescents with diabetes, United States (2016-2019).

  2022cited by this paper
• Consensus Recommendations for the Use of Automated Insulin Delivery Technologies in Clinical Practice

  2022cited by this paper
• Continuous Glucose Monitoring-Guided Insulin Administration in Hospitalized Patients With Diabetes: A Randomized Clinical Trial.

  2022cited by this paper
• Perioperative Fully Closed-Loop Insulin Delivery in Patients Undergoing Elective Surgery: An Open-Label, Randomized Controlled Trial.

  2022cited by this paper
• Time in Range and Pregnancy Outcomes in People with Diabetes Using Continuous Glucose Monitoring

  2022cited by this paper
• The role of mental disorders in precision medicine for diabetes: a narrative review

  2022cited by this paper
• Multicenter Randomized Trial of Intermittently Scanned Continuous Glucose Monitoring Versus Self-Monitoring of Blood Glucose in Individuals With Type 2 Diabetes and Recent-Onset Acute Myocardial Infarction: Results of the LIBERATES Trial

  2022cited by this paper
• "Nothing is linear": Characterizing the Determinants and Dynamics of CGM Use in Older Adults with Type 1 Diabetes.

  2022cited by this paper
• Prevalence of mental disorders in people living with type 1 diabetes: A systematic literature review and meta-analysis.

  2022cited by this paper
• Applying Human Factors Engineering to Address the Telemetry Alarm Problem in a Large Medical Center

  2021cited by this paper
• The Impact of a Recently Approved Automated Insulin Delivery System on Glycemic, Sleep, and Psychosocial Outcomes in Older Adults With Type 1 Diabetes: A Pilot Study

  2021cited by this paper
• Change in Hemoglobin A1c and Quality of Life with Real-Time Continuous Glucose Monitoring Use by People with Insulin-Treated Diabetes in the Landmark Study

  2021cited by this paper
• Facilitators and Barriers to Nursing Implementation of Continuous Glucose Monitoring (CGM) in Critically Ill Patients With COVID-19

  2021cited by this paper
• Management of diabetes and hyperglycaemia in the hospital.

  2021cited by this paper
• Diabetes technologies in people with type 1 diabetes mellitus and disordered eating: A systematic review on continuous subcutaneous insulin infusion, continuous glucose monitoring and automated insulin delivery

  2021cited by this paper
• Efficacy of a Smart Insulin Pen Cap for the Management of Patients with Uncontrolled Type 2 Diabetes: A Randomized Cross-Over Trial

  2021cited by this paper
• Use of Technology in Older Adults with Type 1 Diabetes: Clinical Characteristics and Glycemic Metrics

  2021cited by this paper
• Telemetric Continuous Glucose Monitoring During the COVID-19 Pandemic in Isolated Hospitalized Patients in Denmark: A Randomized Controlled Exploratory Trial

  2021cited by this paper
• Use of Real-Time Continuous Glucose Monitoring Improves Glycemic Control and Other Clinical Outcomes in Type 2 Diabetes Patients Treated with Less Intensive Therapy

  2021cited by this paper
• Closed-Loop Insulin Delivery Versus Sensor-Augmented Pump Therapy in Older Adults With Type 1 Diabetes (ORACL): A Randomized, Crossover Trial.

  2021cited by this paper
• Effectiveness of Continuous Glucose Monitoring in Older Adults with Type 2 Diabetes Treated with Basal Insulin

  2021cited by this paper
• Association between mental health comorbidity and health outcomes in type 2 diabetes mellitus patients

  2020cited by this paper
• Continuous Glucose Monitors and Automated Insulin Dosing Systems in the Hospital Consensus Guideline

  2020cited by this paper
• Older Adults’ Internet Use for Health Information: Digital Divide by Race/Ethnicity and Socioeconomic Status

  2020cited by this paper
• Glucose as the Fifth Vital Sign: A Randomized Controlled Trial of Continuous Glucose Monitoring in a Non-ICU Hospital Setting

  2020cited by this paper
• Efficacy of Bolus Calculation and Advanced Carbohydrate Counting in Type 2 Diabetes: A Randomized Clinical Trial

  2020cited by this paper
• Reducing Inpatient Hypoglycemia in the General Wards Using Real-time Continuous Glucose Monitoring: The Glucose Telemetry System, a Randomized Clinical Trial

  2020cited by this paper
• Effect of Continuous Glucose Monitoring on Hypoglycemia in Older Adults With Type 1 Diabetes: A Randomized Clinical Trial.

  2020cited by this paper
• Using Smartphones and Wearable Devices to Monitor Behavioral Changes During COVID-19

  2020cited by this paper
• Psychosocial Aspects of Diabetes Technology: Adult Perspective.

  2020cited by this paper
• Benefits and Challenges of Diabetes Technology Use in Older Adults.

  2020cited by this paper
• Autism spectrum disorder in children with Type 1 diabetes

  2019cited by this paper
• Implementation of Basal–Bolus Therapy in Type 2 Diabetes: A Randomized Controlled Trial Comparing Bolus Insulin Delivery Using an Insulin Patch with an Insulin Pen

  2019cited by this paper
• Effect of Flash Glucose Monitoring Technology on Glycemic Control and Treatment Satisfaction in Patients With Type 2 Diabetes

  2019cited by this paper
• Continuous glucose monitoring in older people with diabetes and memory problems: a mixed-methods feasibility study in the UK

  2019cited by this paper
• Assessing patient‐reported outcomes for automated insulin delivery systems: the psychometric properties of the INSPIRE measures

  2019cited by this paper
• Fully closed-loop insulin delivery in inpatients receiving nutritional support: a two-centre, open-label, randomised controlled trial

  2019cited by this paper
• Clinical Targets for Continuous Glucose Monitoring Data Interpretation: Recommendations From the International Consensus on Time in Range

  2019cited by this paper
• Disordered Eating Behaviors Are Not Increased by an Intervention to Improve Diet Quality but Are Associated With Poorer Glycemic Control Among Youth With Type 1 Diabetes

  2018cited by this paper
• Continuous Glucose Monitoring Versus Usual Care in Patients With Type 2 Diabetes Receiving Multiple Daily Insulin Injections

  2018cited by this paper
• Near-Continuous Glucose Monitoring Makes Glycemic Control Safer in ICU Patients*

  2018cited by this paper
• “Diabetes Just Tends to Take Over Everything”: Experiences of Support and Barriers to Diabetes Management for Pregnancy in Women With Type 1 Diabetes

  2018cited by this paper
• Women’s Experiences of Day-and-Night Closed-Loop Insulin Delivery During Type 1 Diabetes Pregnancy

  2018cited by this paper
• Closed‐Loop Insulin Delivery for Glycemic Control in Noncritical Care

  2018cited by this paper
• Association of intensive care unit delirium with sleep disturbance and functional disability after critical illness: an observational cohort study

  2018cited by this paper
• Continuous Glucose Monitoring Versus Usual Care in Patients With Type 2 Diabetes Receiving Multiple Daily Insulin Injections: A Randomized Trial.

  2017cited by this paper
• Continuous Glucose Monitoring in Older Adults With Type 1 and Type 2 Diabetes Using Multiple Daily Injections of Insulin: Results From the DIAMOND Trial

  2017cited by this paper
• Use of Flash Glucose-Sensing Technology for 12 months as a Replacement for Blood Glucose Monitoring in Insulin-treated Type 2 Diabetes

  2017cited by this paper
• Closed-loop insulin delivery in inpatients with type 2 diabetes: a randomised, parallel-group trial.

  2017cited by this paper
• Time of Day When Type 1 Diabetes Patients With Eating Disorder Symptoms Most Commonly Restrict Insulin

  2017cited by this paper
• Continuous glucose monitoring in pregnant women with type 1 diabetes (CONCEPTT): a multicentre international randomised controlled trial

  2017cited by this paper
• Behavioural implications of traditional treatment and closed‐loop automated insulin delivery systems in Type 1 diabetes: applying a cognitive restraint theory framework

  2017cited by this paper
• Older Adults Perceptions of Technology and Barriers to Interacting with Tablet Computers: A Focus Group Study

  2017cited by this paper
• Real-Time Continuous Glucose Monitoring Facilitates Feelings of Safety in Older Adults With Type 1 Diabetes: A Qualitative Study

  2017cited by this paper
• Consensus Statement on Inpatient Use of Continuous Glucose Monitoring

  2017cited by this paper
• Closed-Loop Insulin Delivery during Pregnancy in Women with Type 1 Diabetes.

  2016cited by this paper
• Insulin Pumps in Type 1 Diabetes with Mental Disorders: Real-Life Clinical Data Indicate Discrepancies to Recommendations

  2016cited by this paper
• Psychosocial factors in medication adherence and diabetes self-management: Implications for research and practice.

  2016cited by this paper
• Development of a New Measure for Assessing Insulin Delivery Device Satisfaction in Patients with Type 1 and Type 2 Diabetes

  2015cited by this paper
• Insulin Pump Patient Characteristics and Glucose Control in the Hospitalized Setting

  2014cited by this paper
• Is disordered eating behavior more prevalent in adolescents with early-onset type 1 diabetes than in their representative peers?

  2014cited by this paper
• Disinhibited eating and weight-related insulin mismanagement among individuals with type 1 diabetes.

  2014cited by this paper
• Insulin treatment guided by subcutaneous continuous glucose monitoring compared to frequent point-of-care measurement in critically ill patients: a randomized controlled trial

  2014cited by this paper
• Eating disorder in type 1 diabetes can be unmasked by information technology.

  2012cited by this paper
• Short- and Long-Term Effects of Real-Time Continuous Glucose Monitoring in Patients With Type 2 Diabetes

  2011cited by this paper

• Gender Differences in Type 1 Diabetes Management and Mental Health Burden: Findings from a National Survey in Saudi Arabia

  2025cites this paper
• A review of automated insulin delivery use in type 1 diabetes during pregnancy.

  2025cites this paper
• Continuous glucose monitoring in high-risk individuals.

  2025cites this paper